Learn More
Medchemexpress LLC Voacamine | 3371-85-5 | 5 MG

Supplier: Medchemexpress LLC HYN69325MG
Voacamine is an indole alkaloid with cannabinoid 1 (CB1) antagonistic activity. It can inhibit nuclear translocation. Voacamine enhances the effect of Doxorubicin by interfering with P-glycoprotein (P-gp) function. It promotes apoptosis-independent autophagic cell death in human osteosarcoma cells. Voacamine activates the mitochondrial-associated apoptosis signaling pathway and inhibits the PI3K/Akt/mTOR signaling pathway to suppress breast cancer progression. Additionally, Voacamine inhibits EGFR to exert oncogenic activity against colorectal cancer.
- Indole alkaloid
- Acts as a cannabinoid 1 (CB1) antagonist
- Enhances Doxorubicin effect through P-gp interference
- Promotes autophagic cell death in osteosarcoma cells
- Suppresses breast cancer progression by inhibiting PI3K/Akt/mTOR signaling
- Exerts oncogenic activity against colorectal cancer by inhibiting EGFR
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.